Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
697.73B | 642.81B | 631.51B | 607.66B | 592.05B | 627.13B | Gross Profit |
77.74B | 73.60B | 76.51B | 71.58B | 66.19B | 71.83B | EBIT |
27.56B | 23.40B | 28.50B | 27.55B | 24.56B | 29.44B | EBITDA |
52.79B | 49.85B | 52.25B | 50.82B | 46.55B | 51.27B | Net Income Common Stockholders |
15.59B | 14.56B | 19.01B | 17.25B | 16.66B | 25.85B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
82.87B | 83.47B | 109.75B | 108.49B | 103.05B | 110.05B | Total Assets |
775.97B | 689.52B | 703.89B | 685.27B | 672.25B | 657.24B | Total Debt |
82.45B | 37.34B | 40.47B | 39.48B | 38.97B | 14.28B | Net Debt |
8.88B | -42.94B | -66.28B | -55.01B | -37.49B | -81.57B | Total Liabilities |
323.31B | 253.95B | 254.17B | 251.75B | 249.61B | 227.33B | Stockholders Equity |
427.01B | 430.38B | 444.85B | 429.89B | 419.26B | 423.26B |
Cash Flow | Free Cash Flow | ||||
28.44B | 25.04B | 14.34B | 16.14B | 3.23B | 270.00M | Operating Cash Flow |
64.12B | 48.44B | 39.27B | 45.53B | 38.69B | 34.96B | Investing Cash Flow |
-76.12B | -25.51B | -29.59B | -31.79B | -27.97B | -18.05B | Financing Cash Flow |
26.78B | -48.65B | -8.17B | -7.88B | -10.49B | -21.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$2.28B | 20.92 | 4.60% | 4.26% | ― | ― | ||
66 Neutral | $4.51B | 12.29 | 5.40% | 248.53% | 4.14% | -12.41% | |
€835.40M | 15.33 | 2.96% | 2.12% | ― | ― | ||
77 Outperform | ¥108.82B | 12.11 | 3.72% | 3.56% | 4.86% | ||
75 Outperform | ¥21.96B | 9.20 | 3.26% | 3.60% | 16.83% | ||
74 Outperform | ¥17.13B | 7.42 | 2.75% | 1.73% | -2.77% | ||
65 Neutral | ¥11.24B | 10.07 | 4.88% | 2.56% | 168.27% |